StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: MAP Pharmaceuticals Inc

Enter Symbol or Keywords

OPS Ranking of "7" Reiteration for MAP Pharmaceuticals

Stock Quote: (NGM:MAPP)

11/11/2009

14.98

-0.05

-0.33%

110,074

OPS Ranking of "7" Reiteration for MAP Pharmaceuticals

Last

Price Change

% Chg

Volume

Sarasota, FL, November 11, 2009-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "7" for MAP Pharmaceuticals, Inc. (NASDAQ:MAPP). MAP Pharmaceuticals has had an OPS Ranking of ... read full story

Website Address:	www.mappharma.com
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: MAPP

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: MAPP

11/13/2009

EBITDA Turns Positive for MAP Pharmaceuticals' Third Quarter

11/11/2009

OPS Ranking of "7" Reiteration for MAP Pharmaceuticals

11/11/2009

StockDiagnostics.com Has Issued a Cashless Earnings Warning For MAP Pharmaceuticals

... more MAPP exclusives

Other News Sources: MAPP

02/03/2010

MAPP: Jumps +4.46%; Vol +137%; Last 90 Min of Trading

01/11/2010

MAP Pharmaceuticals Announces FDA will not Require a Second Pivotal Efficacy Study for LEVADEX(TM) NDA Submission

01/06/2010

MAP Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference

... more MAPP news from other sources

Daily Market Updates

02/09/2010

Markets Close Day After Strong Rally as Concerns Ease re Greece

Stocks closed today's strong rally following speculation that the European Union will step in to bail out Greece. Germany and its European Union partners are expected to offer Greece and other troubled EU members loan guarantees. Oil climbed almost $ ... read full story